Dr Simon Kollnberger

2025

• Bayliss, R. J. et al. 2025. An αvβ6 specific precision virotherapy expressing bispecific immune cell activators induces immune cell activation and mediates tumour cell death. Molecular Therapy Oncology 33 (3) 201017. (10.1016/j.omton.2025.201017)
• Davies, K. et al. 2025. NKG2A-mediated immune modulation of natural killer cells by Staphylococcus aureus. The Journal of Immunology vkaf174. (10.1093/jimmun/vkaf174)
• Gao, Y. et al., 2025. Identification of soluble biomarkers that associate with distinct manifestations of long COVID. Nature Immunology 26 , pp.692–705. (10.1038/s41590-025-02135-5)
• Ponsford, M. et al. 2025. TAP-I Deficiency presenting with chronic granulomatous rubella virus-driven cutaneous ulceration: a case report and scoping literature review. Journal of Clinical Immunology (10.1007/s10875-025-01919-6)

2024

• Kite, J. et al., 2024. Downregulation of endogenous nectin1 in human keratinocytes by herpes simplex virus 1 glycoprotein D excludes superinfection but does not affect NK cell function. Journal of General Virology 105 (3)(10.1099/jgv.0.001969)

2023

• Rubina, A. et al. 2023. ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways. Proceedings of the National Academy of Sciences 120 (33) e2303155120. (10.1073/pnas.2303155120)
• Shepherd, F. R. et al. 2023. The superantigens SpeC and TSST-1 specifically activate TRBV12-3/12-4+ memory T cells. Communications Biology 6 78. (10.1038/s42003-023-04420-1)
• Vlachava, V. et al. 2023. HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activation. Proceedings of the National Academy of Sciences 120 (49) e2309077120. (10.1073/pnas.2309077120)

2022

• Pymm, P. et al., 2022. Epitope length variants balance protective immune responses and viral escape in HIV-1 infection. Cell Reports 38 (9) 110449. (10.1016/j.celrep.2022.110449)

2019

• Busch, R. , Kollnberger, S. and Mellins, E. D. 2019. HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications. Nature Reviews Rheumatology 15 (6), pp.364-381. (10.1038/s41584-019-0219-5)

2018

• Boelen, L. et al., 2018. Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1. Science Immunology 3 (29) eaao2892. (10.1126/sciimmunol.aao2892)
• Kajikawa, M. et al., 2018. Structure of MHC class I-like MILL2 reveals heparan-sulfate binding and interdomain flexibility. Nature Communications 9 (1) 4330. (10.1038/s41467-018-06797-8)

2017

• Neerinckx, B. et al., 2017. No evidence for a direct role of HLA-B27 in pathological bone formation in axial SpA. RMD Open 3 (1) e000451. (10.1136/rmdopen-2017-000451)

2016

• Chen, L. et al., 2016. Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis. Annals of the Rheumatic Diseases 75 (5), pp.916-925. (10.1136/annrheumdis-2014-206996)
• Kollnberger, S. 2016. The role of HLA-class I heavy-chain interactions with killer-cell immunoglobulin-like receptors in immune regulation. Critical Reviews in Immunology 36 (3), pp.269-282. (10.1615/CritRevImmunol.2016017965)
• Rysnik, O. et al., 2016. Data showing non-conventional HLA-B27 expression in axial joints and gut tissue from B27 transgenic rats, and in frozen and paraffin-fixed synovial SpA tissue. Data in Brief 9 , pp.100-111. (10.1016/j.dib.2016.08.046)
• Rysnik, O. et al., 2016. Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue. Journal of Autoimmunity 70 , pp.12-21. (10.1016/j.jaut.2016.03.009)

2015

• Antoniou, A. N. et al., 2015. HLA-B27-homodimer-specific antibody modulates the expansion of pro-inflammatory T-cells in HLA-B27 transgenic rats. PLoS ONE 10 (6) e0130811. (10.1371/journal.pone.0130811)